BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 33499905)

  • 21. Health and socio-demographic implications of the Covid-19 second pandemic wave in Israel, compared with the first wave.
    Birenbaum-Carmeli D; Chassida J
    Int J Equity Health; 2021 Jul; 20(1):154. PubMed ID: 34215274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Vaccination in Palestine/Israel: Citizenship, Capitalism, and the Logic of Elimination.
    Howard N; Schneider E
    Health Hum Rights; 2022 Dec; 24(2):265-279. PubMed ID: 36579317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan.
    Lahav E; Shahrabani S; Rosenboim M; Tsutsui Y
    Eur J Health Econ; 2022 Jun; 23(4):687-703. PubMed ID: 34677722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel.
    Heller O; Chun Y; Shlomo Y; Gewirtz-Meydan A; Acri M; Kulkarni S; Grinstein-Weiss M
    Vaccine; 2022 Mar; 40(13):2053-2061. PubMed ID: 35168839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. It Takes Two to Tango: How the COVID-19 Vaccination Campaign in Israel Was Framed by the Health Ministry vs. the Television News.
    Gesser-Edelsburg A; Hijazi R; Cohen R
    Front Public Health; 2022; 10():887579. PubMed ID: 35493372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicians' Perspective on Vaccine-Hesitancy at the Beginning of Israel's COVID-19 Vaccination Campaign and Public's Perceptions of Physicians' Knowledge When Recommending the Vaccine to Their Patients: A Cross-Sectional Study.
    Gesser-Edelsburg A; Badarna Keywan H
    Front Public Health; 2022; 10():855468. PubMed ID: 35356022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons from Israel's COVID-19 Green Pass program.
    Kamin-Friedman S; Peled Raz M
    Isr J Health Policy Res; 2021 Oct; 10(1):61. PubMed ID: 34715931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Israel's COVID-19 endgame.
    Balicer RD; Ohana R
    Science; 2021 May; 372(6543):663. PubMed ID: 33986155
    [No Abstract]   [Full Text] [Related]  

  • 29. Strategy drives implementation: COVID vaccination in Israel.
    Glied S
    Isr J Health Policy Res; 2021 Feb; 10(1):9. PubMed ID: 33522945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Israel's high case plateau may offer worrisome portent.
    Wadman M
    Science; 2021 Sep; 373(6562):1428-1429. PubMed ID: 34554791
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
    Liu X; Munro APS; Wright A; Feng S; Janani L; Aley PK; Babbage G; Baker J; Baxter D; Bawa T; Bula M; Cathie K; Chatterjee K; Dodd K; Enever Y; Fox L; Qureshi E; Goodman AL; Green CA; Haughney J; Hicks A; Jones CE; Kanji N; van der Klaauw AA; Libri V; Llewelyn MJ; Mansfield R; Maallah M; McGregor AC; Minassian AM; Moore P; Mughal M; Mujadidi YF; Belhadef HT; Holliday K; Osanlou O; Osanlou R; Owens DR; Pacurar M; Palfreeman A; Pan D; Rampling T; Regan K; Saich S; Saralaya D; Sharma S; Sheridan R; Stokes M; Thomson EC; Todd S; Twelves C; Read RC; Charlton S; Hallis B; Ramsay M; Andrews N; Lambe T; Nguyen-Van-Tam JS; Cornelius V; Snape MD; Faust SN;
    J Infect; 2023 Jul; 87(1):18-26. PubMed ID: 37085049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of ethnic, gender and educational differences in attitudes toward COVID-19 vaccines in Israel - implications for vaccination implementation policies.
    Green MS; Abdullah R; Vered S; Nitzan D
    Isr J Health Policy Res; 2021 Mar; 10(1):26. PubMed ID: 33741063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.
    Raz A; Keshet Y; Popper-Giveon A; Karkabi MS
    Vaccine; 2021 Jul; 39(30):4027-4028. PubMed ID: 34120767
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of geo-political socio-economic factors on vaccine dissemination trends: a case-study on COVID-19 vaccination strategies.
    Chauhan R; Varma G; Yafi E; Zuhairi MF
    BMC Public Health; 2023 Nov; 23(1):2142. PubMed ID: 37919737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blunting COVID-19's negative impact: Lessons from Israel's vaccination campaign.
    Tsigaris P; Teixeira da Silva JA
    Travel Med Infect Dis; 2021; 41():102029. PubMed ID: 33737163
    [No Abstract]   [Full Text] [Related]  

  • 37. Age, ageing, ageism and "age-itation" in the Age of COVID-19: rights and obligations relating to older persons in Israel as observed through the lens of medical ethics.
    Clarfield AM; Jotkowitz A
    Isr J Health Policy Res; 2020 Nov; 9(1):64. PubMed ID: 33183358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans.
    Young-Xu Y; Korves C; Roberts J; Powell EI; Zwain GM; Smith J; Izurieta HS
    JAMA Netw Open; 2021 Oct; 4(10):e2128391. PubMed ID: 34613401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Israel's population: the challenge of pluralism.
    Friedlander D; Goldscheider C
    Popul Bull; 1984 Apr; 39(2):3-39. PubMed ID: 12312873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.